Standard BioTools Inc.
Balance Sheet
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $270.0M | $265.8M | $120.9M | $129.4M | $158.6M | $150.9M | $166.7M | $210.6M |
| Accounts Receivable | $15.7M | $16.6M | $13.4M | $13.5M | $14.6M | $35.5M | $14.7M | $35.3M |
| Inventory | $17.1M | $18.6M | $20.0M | $25.4M | $24.2M | $42.1M | $20.7M | $42.6M |
| Total Current Assets | $516.9M | $521.5M | $454.3M | $472.4M | $506.0M | $344.0M | $375.9M | $453.6M |
| Property, Plant & Equipment | $15.3M | $17.1M | $19.3M | $20.7M | $22.7M | $43.6M | $22.8M | $42.0M |
| Goodwill | — | — | — | — | — | $111.7M | $111.3M | $106.3M |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — | $28.1M | $29.0M | $23.4M |
| Total Assets | $627.2M | $639.1M | $567.8M | $539.6M | $557.0M | $579.6M | $612.3M | $681.5M |
| Liabilities | ||||||||
| Accounts Payable | $9.6M | $8.0M | $5.4M | $6.6M | $7.3M | $11.8M | $5.0M | $10.9M |
| Total Current Liabilities | $56.8M | $42.2M | $108.3M | $108.0M | $98.0M | $56.2M | $65.9M | $120.6M |
| Long-Term Debt | — | — | — | — | — | — | $299.0K | $55.2M |
| Total Liabilities | $87.2M | $78.0M | $143.5M | $140.0M | $132.4M | $125.0M | $140.6M | $192.2M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-1.16B | $-1.13B | $-1.26B | $-1.28B | $-1.25B | $-1.21B | $-1.19B | $-1.15B |
| Total Stockholders' Equity | $540.0M | $561.1M | $424.3M | $399.7M | $424.5M | $454.6M | $471.7M | $489.3M |